Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
Lung
.
2022 Feb;200(1):19.
doi: 10.1007/s00408-022-00516-3.
Authors
Jamie L Todd
1
2
,
Megan L Neely
3
4
,
Robert Overton
3
,
Hillary Mulder
3
,
Jesse Roman
5
,
Joseph A Lasky
6
,
Joao A de Andrade
7
,
Mridu Gulati
8
,
Howard Huang
9
,
Thomas B Leonard
10
,
Christian Hesslinger
11
,
Imre Noth
12
,
John A Belperio
13
,
Kevin R Flaherty
14
,
Scott M Palmer
3
4
;
IPF-PRO Registry investigators
Affiliations
1
Duke Clinical Research Institute, DUMC Box 103002, Durham, NC, 27710, USA.
[email protected]
.
2
Duke University Medical Center, Durham, NC, USA.
[email protected]
.
3
Duke Clinical Research Institute, DUMC Box 103002, Durham, NC, 27710, USA.
4
Duke University Medical Center, Durham, NC, USA.
5
Jane and Leonard Korman Respiratory Institute, Philadelphia, PA, USA.
6
School of Medicine, Tulane University, New Orleans, LA, USA.
7
Vanderbilt University School of Medicine, Nashville, TN, USA.
8
Yale School of Medicine, New Haven, CT, USA.
9
Houston Methodist Hospital, Houston, TX, USA.
10
Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.
11
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
12
Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA.
13
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
14
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
PMID:
35166906
PMCID:
PMC8881254
DOI:
10.1007/s00408-022-00516-3
No abstract available
Publication types
Published Erratum
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States